AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Telix Pharmaceuticals (ASX:TLX) Acquires RLS in Major US Expansion, Shares Decline Amid Market Weakness
September 23, 2024 01:11 PM AEST| By Team Kalkine MediaTelix Pharmaceuticals Ltd (ASX:TLX) is making headlines with its recent acquisition of RLS Group for AU$ 230 million in cash, along with a potential deferred cash consideration of up to $20 million. Despite this significant move to strengthen its pos...
Healius Divests Lumus Imaging in $965 Million Deal to Reduce Debt
September 23, 2024 10:05 AM AEST| By Team Kalkine MediaHealius Limited (ASX:HLS) has announced plans to divest Lumus Imaging for a substantial sum of $965 million. The deal, which is set to pay down debt and generate returns for investors, is being executed with Affinity Equity Partners, an Asian private...
Telix Pharmaceuticals Expands North American Operations with RLS Acquisition
September 23, 2024 09:52 AM AEST| By Team Kalkine MediaTelix Pharmaceuticals Ltd (ASX:TLX), based in Melbourne, is set to significantly expand its presence in North America through the acquisition of RLS Inc., the only US radiopharmacy network accredited by the Joint Commission. This strategic move will...
Door Opens to COVID Business Interruption Claims
September 23, 2024 09:51 AM AEST| By Team Kalkine MediaA recent Federal Court of Australia class action ruling has opened the path for business customers with business interruption policies during the COVID-19 lockdowns to pursue claims against Insurance Australia Group (ASX:IAG). This decision follows a...
Leukemia Foundation Urges Registration of Stem Cell Donors in Battle Against Blood Cancers
September 20, 2024 07:34 PM AEST| By Team Kalkine MediaThe Leukemia Foundation is calling on Australians to address a critical shortage of registered stem cell donors in anticipation of World Marrow Donor Day. Together with the Australian Bone Marrow Donor Registry (ABMDR), the Foundation urges all Austr...
RMD and Netwealth Group Ltd: 2 ASX Shares Worth Exploring
September 20, 2024 07:32 PM AEST| By Team Kalkine MediaThe ResMed CDI,(ASX: RMD),share price has surged by 39.1% since the beginning of 2024, while Netwealth Group Ltd (ASX: NWL) has seen its share price recover, currently sitting 96.9% above its 52-week lows. Both companies represent key players in thei...
Is It Time to Pay Attention to PME Shares?
September 20, 2024 06:46 PM AEST| By Team Kalkine MediaPro Medicus Limited,(ASX: PME),has garnered attention due to its notable performance in 2024, with the company’s share price rising by a substantial margin since the beginning of the year. Pro Medicus specializes in radiology IT software for healthca...
Regis Healthcare Reaches Nine-Year High on Strategic Acquisition
September 20, 2024 05:50 PM AEST| By Team Kalkine MediaRegis Healthcare (ASX: REG) has surged to an impressive intraday peak of $6.12, marking its highest price since 2015. This notable increase is largely attributed to the company’s announcement of plans to acquire two aged care homes for $35.5 million,...
Regis Healthcare (ASX: REG) Share Price Rises on Acquisition and Aged Care Reforms
September 20, 2024 04:09 PM AEST| By Team Kalkine MediaRegis Healthcare Ltd,(ASX: REG),has seen its share price rise by 4% following the announcement of a significant acquisition and a response to recent aged care reforms.As one of Australia's largest aged care operators, Regis, an,ASX healthcare stock,,...
REG Acquires Two Melbourne Aged Care Facilities for $35.5 Million
September 20, 2024 03:07 PM AEST| By Team Kalkine MediaRegis Healthcare Limited (ASX: REG), a leading provider of aged care services in Australia, has announced the acquisition of two aged care facilities in Melbourne from Ti Tree Operations for $35.5 million. This strategic acquisition, funded entirely...
CSL Ltd (ASX:CSL) Announces Leadership Changes: John Levy Steps in as Interim CFO
September 20, 2024 02:27 PM AEST| By Team Kalkine MediaCSL Ltd (ASX:CSL), a global leader in biotechnology, has announced significant leadership changes within its financial department. John Levy will assume the role of Interim Chief Financial Officer (CFO), while Joy Linton, the outgoing CFO, transition...
Health Check: Cann Group Experiences Earnings Turnaround Amidst Challenges
September 20, 2024 01:13 AM AEST| By Team Kalkine MediaCann Group (ASX: CAN), a pioneer in the medical cannabis sector, is signaling a turnaround after facing significant challenges. The company, which posted a $13.2 million loss for the 2023-24 financial year, is targeting a return to underlying earning...
ResMed Shares Take a Hit on Thursday. Here’s Why.
September 19, 2024 03:32 PM AEST| By Team Kalkine MediaShares of ResMed (ASX:RMD) are experiencing a significant decline on Thursday, with the stock down 3.5% to AU$34.98 after opening at AU$35.30, compared to yesterday's close of $36.25. This downturn is notable against the backdrop of a generally rough...
Key Reasons to Keep an Eye on CSL Ltd and Pro Medicus Shares
September 19, 2024 03:23 PM AEST| By Team Kalkine MediaSince the beginning of 2024, shares of CSL Ltd have risen by 2.5%, while Pro Medicus Limited is trading just 1.3% away from its 52-week high. Let’s take a closer look at what’s driving interest in these two,ASX healthcare stocks,and why they could be...
Surge in Yoghurt Sales Boosts Bega's Market Value
September 19, 2024 12:32 PM AEST| By Team Kalkine MediaBega Cheese Limited (ASX: BGA), a major player in the Australian dairy industry, has experienced a significant increase in market capitalisation, adding approximately $700 million over the past nine months. This rise marks a return to valuation level...
Ramsay Health Care Limited (ASX:RHC) Price-to-Earnings Ratio: A Closer Look
September 19, 2024 10:30 AM AEST| By Team Kalkine MediaRamsay Health Care Limited (ASX:RHC) currently holds a price-to-earnings (P/E) ratio of 36.3x, significantly higher than the market average in Australia, where nearly half of the listed companies trade below a P/E ratio of 19x. On the surface, this e...
Does LuPSMA Represent a Breakthrough in Treating Metastatic Prostate Cancer?
September 18, 2024 04:20 PM AEST| By Team Kalkine MediaA significant study conducted by the,Peter MacCallum Cancer Centre,(Peter Mac) has demonstrated the potential of targeted radioactive infusion for enhancing treatment outcomes in metastatic prostate cancer, with implications for earlier-stage disease...
FDA Provides Guidance for Paradigm Biopharma's Phase 3 Osteoarthritis Trial: A Closer Look
September 18, 2024 10:27 AM AEST| By Team Kalkine MediaParadigm Biopharmaceuticals (ASX:PAR) has received significant feedback from the U.S. Food and Drug Administration (FDA) regarding its Phase 3 clinical trial for knee osteoarthritis. The FDA's recent communication highlights a need for adjustments to...
Botanix Pharmaceuticals Ltd (ASX: BOT) to Launch Sofdra for Excessive Sweating in the US
September 17, 2024 06:09 PM AEST| By Team Kalkine MediaBotanix Pharmaceuticals Ltd (ASX: BOT) has announced an upcoming launch of its approved product, Sofdra, for treating primary axillary hyperhidrosis (PAH), a condition causing excessive sweating. The product is expected to hit the US market in the Ma...
Pacific Smiles Group (ASX:PSQ) Receives New Takeover Offer from Beam Dental Bidco
September 17, 2024 10:37 AM AEST| By Team Kalkine MediaPacific Smiles Group Ltd (ASX:PSQ), a prominent dental centre operator in Australia, has recently received an off-market takeover proposal from Beam Dental Bidco Pty Ltd, an unlisted Australian entity. Beam Dental Bidco is associated with Genesis Cap...
Advertise your brand on Kalkine Media